These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33295096)
1. MBNL1 regulates isoproterenol-induced myocardial remodelling in vitro and in vivo. Xu Y; Liang C; Luo Y; Zhang T J Cell Mol Med; 2021 Jan; 25(2):1100-1115. PubMed ID: 33295096 [TBL] [Abstract][Full Text] [Related]
2. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. Wang K; Long B; Zhou J; Li PF J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053 [TBL] [Abstract][Full Text] [Related]
3. The mechanism of myocardial hypertrophy regulated by the interaction between mhrt and myocardin. Luo Y; Xu Y; Liang C; Xing W; Zhang T Cell Signal; 2018 Mar; 43():11-20. PubMed ID: 29199045 [TBL] [Abstract][Full Text] [Related]
4. LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p/KLF4/myocardin axis. Xu Y; Luo Y; Liang C; Zhang T J Mol Cell Cardiol; 2020 Feb; 139():47-61. PubMed ID: 31982428 [TBL] [Abstract][Full Text] [Related]
5. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity. Yoshida T; Yamashita M; Horimai C; Hayashi M J Biol Chem; 2014 Sep; 289(38):26107-26118. PubMed ID: 25100730 [TBL] [Abstract][Full Text] [Related]
6. HuR regulates phospholamban expression in isoproterenol-induced cardiac remodelling. Hu H; Jiang M; Cao Y; Zhang Z; Jiang B; Tian F; Feng J; Dou Y; Gorospe M; Zheng M; Zheng L; Yang Z; Wang W Cardiovasc Res; 2020 Apr; 116(5):944-955. PubMed ID: 31373621 [TBL] [Abstract][Full Text] [Related]
7. Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation. Grisanti LA; Repas AA; Talarico JA; Gold JI; Carter RL; Koch WJ; Tilley DG Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H316-30. PubMed ID: 25485901 [TBL] [Abstract][Full Text] [Related]
8. Zinc Finger Protein ZBTB20 protects against cardiac remodelling post-myocardial infarction via ROS-TNFα/ASK1/JNK pathway regulation. Li F; Yang Y; Xue C; Tan M; Xu L; Gao J; Xu L; Zong J; Qian W J Cell Mol Med; 2020 Nov; 24(22):13383-13396. PubMed ID: 33063955 [TBL] [Abstract][Full Text] [Related]
9. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway. Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235 [TBL] [Abstract][Full Text] [Related]
10. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation. Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704 [TBL] [Abstract][Full Text] [Related]
11. MiR-466h-5p induces expression of myocardin with complementary promoter sequences. Luo Y; Liang C; Xu Y; Zhang T Biochem Biophys Res Commun; 2019 Jun; 514(1):187-193. PubMed ID: 31029421 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR. Yin Q; Yang C; Wu J; Lu H; Zheng X; Zhang Y; Lv Z; Zheng X; Li Z PLoS One; 2016; 11(4):e0152005. PubMed ID: 27035432 [TBL] [Abstract][Full Text] [Related]
13. p300 protein as a coactivator of GATA-5 in the transcription of cardiac-restricted atrial natriuretic factor gene. Kakita T; Hasegawa K; Morimoto T; Kaburagi S; Wada H; Sasayama S J Biol Chem; 1999 Nov; 274(48):34096-102. PubMed ID: 10567378 [TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling. Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063 [TBL] [Abstract][Full Text] [Related]
15. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart. Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330 [TBL] [Abstract][Full Text] [Related]